Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ciba Self-Medication president will be Zyma's Remo Denti, succeeding Peter Mayer.

This article was originally published in The Tan Sheet

Executive Summary

CIBA SELF-MEDICATION PRESIDENT WILL BE REMO DENTI, the current head of Ciba-Geigy Ltd.'s Zyma SA subsidiary headquartered in Nyon, Switzerland. Denti will succeed Peter Mayer, PhD, as president of U.S.-based Ciba Self-Medication and head of Self-Medication, North America, effective June 1. Ciba announced to employees on April 26 that Mayer was leaving the company due to "philosophical differences with regard to the management of the North America business."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083813

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel